Bajaj Healthcare Details Fund Use as ₹52.71 Cr Warrant Funds Arrive
Bajaj Healthcare Ltd. has confirmed the utilization of funds raised through its preferential issue and warrant conversion. The company reported receiving ₹52.71 Crores in the fourth quarter of fiscal year 2026 from the exercise of warrant conversions.
Total Funds Deployed
As of March 31, 2026, Bajaj Healthcare had utilized ₹173 Crores of the total ₹207 Crores raised. These funds were allocated to key areas as per the company's initial plans.
Allocation Breakdown
The deployed capital was primarily directed towards loan repayment, accounting for ₹150 Crores. Additionally, ₹3.16 Crores were allocated to capital expenditure, and ₹19.84 Crores were used for general corporate purposes.
Investor Transparency and Capex Focus
This confirmation provides investors with transparency on fund management, reinforcing confidence in the company's governance. However, the filing highlights a slow pace in capital expenditure deployment, with only ₹3.16 Crores utilized out of an indicated ₹35 Crores for capex. This suggests potential delays or a more gradual timeline for planned expansion or asset upgrades, which remains a watchpoint for investors.
